Racial differences in serum chemokines in prostate cancer patients.

Dev KaranJo WickSeema DubeyChandan Kumar-SinhaJaved SiddiquiLakshmi P KunjuKenneth A IczkowskiArul M Chinnaiyan

Published in: Cancer (2023)

Lower levels of CCL23 in AA prostate cancer patient sera and tumor tissues and high CXCL2 and CXCL5 may contribute to aggressive prostate cancer, as often seen in AA men. The disproportionate levels of serum chemokines associated with race warrant further exploration to improve equitability in precision oncology to benefit prostate cancer patients.

Keyphrases

prostate cancer
radical prostatectomy
gene expression
palliative care
case report
liver injury
middle aged
benign prostatic hyperplasia
drug induced